Title: Managing resistance to anti-HIV drugs: an important consideration for effective disease management
Authors: Vandamme, Anne-Mieke ×
Van Laethem, Kristel
De Clercq, Erik #
Issue Date: Mar-1999
Series Title: Drugs vol:57 issue:3 pages:337-61
Abstract: Current recommendations for the treatment of HIV-infected patients advise highly active antiretroviral therapy (HAART) consisting of combinations of 3 or more drugs to provide long-term clinical benefit. This is because only a complete suppression of virus replication will be able to prevent virus drug resistance, the main cause of drug failure. Virus drug resistance may remain a cause of concern in patients who have already received suboptimal mono- or bitherapy, or for patients who do not experience complete shut-down of virus replication under HAART. For these patients, replacement of one combination therapy regimen by another at drug failure, taking into account the existing resistance profile, will be needed. The development of new drugs will remain necessary for those patients who have failed to respond to all currently available drugs, as will be the institution of more effective and less toxic HAART regimens.
ISSN: 0012-6667
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Laboratory of Clinical and Epidemiological Virology (Rega Institute)
Laboratory of Virology and Chemotherapy (Rega Institute)
× corresponding author
# (joint) last author

Files in This Item:
File Status SizeFormat
Vandamme_ManagingResistance_Drugs1999.pdf Published 178KbAdobe PDFView/Open


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science